Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹81,508Accepted-AOC 146 B 166 A UNIT NO 7 8 9 8TH FLOOR R CITY OFFICE R CITY MALL LAL BAHADUR SHASTRI MARG GHATKOPAR MUMBAI MAHARASHTRA 400086 | MUMBAI SUBURBAN | MAHARASHTRA | 400086 | L1 | Accepted-AOC L1 | |
| 2 | L1₹5.0 LAccepted-AOC 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | L1 | Accepted-AOC L1 | |
| 3 | L1₹5.5 LAccepted-AOC 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | L1 | Accepted-AOC L1 |
Tender Value
₹11.1 L
EMD Value
₹50,000
Closing Date
4 Aug 2023, 4:00 pmClosed
Director of Health Services
Directorate of Health Services, Agartala, Tripura
Tender for procurement of Medicine (Factor Injection)
2023_HF_40228_1
No.F.5-II(1)/Store/Fact/Med/24
Open Tender
Medicines
Lump-sum
TRIPURA
Please refer Tender documents.
8 documents required · 8 mandatory
₹1,000
₹50,000
Yes
Recreation Hall, Directorate of Health Services,
24 Aug 2023
20 Jul 2023
4 Aug 2023
20 Jul 2023
4 Aug 2023
20 Jul 2023
20 Jul 2023 - 25 Jul 2023
26 Jul 2023
Inj.Anti-inhibitor Coagulatin Complex 1000IU
Inj.Anti-inhibitor Coagulatin Complex 500IU
Inj. Recombinant Factor VIIa 1mg
Inj. Recombinant Factor VIIa 2mg
Inj. Emicizumab 30mg/ml
Takeda Biopharmaceuticals India Private Limited
Novo Nordisk India Private Limited
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.PDF
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .